Effect of Threshold Pressure-Loaded RMT + tTBS on Respiratory Function in SCI Patients
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT07050069, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Shengjing Hospital
- Trial code
- NCT07050069
- Record updated
- 3 July 2025
- Original description
The purpose of this clinical trial is to understand whether threshold pressure load respiratory muscle training combined with iTBS can effectively improve the respiratory function of SCI patients. The main questions it aims to answer are:Read full original descriptionShow less
The Effect of Threshold Pressure-loaded Respiratory Muscle Training Combined With Transcranial Intermittent Theta Burst Stimulation on Respiratory Function in Patients With Spinal Cord Injury
The purpose of this clinical trial is to understand whether threshold pressure load respiratory muscle training combined with iTBS can effectively improve the respiratory function of SCI patients. The main questions it aims to answer are:
* The impact of threshold pressure load respiratory muscle training on the respiratory function of SCI patients. * The impact of iTBS treatment at the cortical projection point of the diaphragm on the respiratory function of SCI patients. * Whether the combination of the above two treatment techniques is superior to single treatment.
Inclusion: Patients with spinal cord injury (SCI) meeting the 2019 revised International Standards for Neurological Classification of Spinal Cord Injury by the American Spinal Injury Association (ASIA), confirmed by CT/MRI; Aged 18-80 years; Time since injury: 2 weeks to 6 months, with spinal shock resolved; Injury level at T12 or above, ASIA Impairment Scale (AIS) grade A-C; Patients providing written informed consent after study explanation.
Exclusion: Contraindications to magnetic stimulation: intracranial metal implants, pacemakers, etc; Patients with severe cardiorespiratory diseases (e.g., pneumothorax); Unstable vital signs (e.g., hypotension, arrhythmia); Cognitive/psychiatric disorders precluding cooperation; Requiring mechanical ventilation; Congenital spinal/limb deformities.